Zhejiang Anglikang Pharmaceutical Co.Ltd(002940) (SZ Zhejiang Anglikang Pharmaceutical Co.Ltd(002940) , closing price: 41.34 yuan) the annual performance report released on April 16 said that the operating revenue in 2021 was about 1.38 billion yuan, a year-on-year increase of 7.04%; The net profit attributable to the shareholders of the listed company was about 120 million yuan, a year-on-year decrease of 26.8%; The basic earnings per share was 1.27 yuan, a year-on-year decrease of 29.83%. It is proposed to pay a cash dividend of 3 yuan (including tax) for every 10 shares, no bonus shares and no increase.
From January to December 2021, the composition of the operating revenue of Zhejiang Anglikang Pharmaceutical Co.Ltd(002940) .
Zhejiang Anglikang Pharmaceutical Co.Ltd(002940) ‘s chairman is Fang Nanping, male, 55 years old, with a bachelor’s degree; The general manager is Jiang Zhenshan, male, 53, with a bachelor’s degree.
